Published in Curr Med Res Opin on October 05, 2011
HDL and cognition in neurodegenerative disorders. Neurobiol Dis (2014) 0.84
Fractional diastolic and systolic pressure in the ascending aorta are related to the extent of coronary artery disease. Am J Hypertens (2004) 2.21
The value of ECG parameters in estimating myocardial injury and establishing prognosis in patients with acute pulmonary embolism. Kardiol Pol (2011) 1.60
How often pulmonary embolism mimics acute coronary syndrome? Kardiol Pol (2011) 1.58
The prognostic value of ST-segment elevation in the lead aVR in patients with acute pulmonary embolism. Kardiol Pol (2011) 1.48
Effects of phosphodiesterase inhibitors on the inflammatory response of endothelial cells stimulated by myeloperoxidase-modified low-density lipoprotein or tumor necrosis factor alpha. Eur Urol (2009) 1.45
Increased prevalence of cardiovascular risk factors in patients with acute coronary syndrome and indications for treatment with oral anticoagulation. Kardiol Pol (2011) 1.40
Efficacy and Safety of Novel NovaCross Microcatheter for Chronic Total Occlusions: First-in-Human Study. J Invasive Cardiol (2016) 1.39
Giant drug-induced QT prolongation > 800 ms with alternans of terminal portion of T wave and J wave in a normothermic patient. Kardiol Pol (2013) 1.39
Acute hyperglycaemia and inflammation in patients with ST segment elevation myocardial infarction. Kardiol Pol (2013) 1.37
Prognostic significance of ST segment changes in lead aVR in patients with acute inferior myocardial infarction with ST segment elevation. Kardiol Pol (2012) 1.37
Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia. Am Heart J (2007) 0.94
[Pseudo-Wellens syndrome in a patient with vasospastic angina]. Kardiol Pol (2011) 0.93
Lambda-like ST segment elevation in acute myocardial infarction - a new risk marker for ventricular fibrillation? Three case reports. Kardiol Pol (2008) 0.91
Sleep restriction increases white blood cells, mainly neutrophil count, in young healthy men: a pilot study. Vasc Health Risk Manag (2008) 0.90
Ascending aortic, but not brachial blood pressure-derived indices are related to coronary atherosclerosis. Atherosclerosis (2004) 0.86
[Epileptic asystole - a case report]. Kardiol Pol (2012) 0.84
Thiol-containing molecules interact with the myeloperoxidase/H2O2/chloride system to inhibit LDL oxidation. Biochem Biophys Res Commun (2005) 0.84
Triggering of inflammatory response by myeloperoxidase-oxidized LDL. Biochem Cell Biol (2006) 0.84
Monocyte-platelet complexes on CD14/CD16 monocyte subsets: relationship with ApoA-I levels. A preliminary study. Cardiovasc Pathol (2007) 0.83
Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100. J Lipid Res (2014) 0.83
Electrocardiography and prognosis of patients with acute pulmonary embolism. Cardiol J (2011) 0.82
Exposure of endothelial cells to physiological levels of myeloperoxidase-modified LDL delays pericellular fibrinolysis. PLoS One (2012) 0.81
Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs: flufenamic acid and its 5-chloro-derivative directly interact with a recombinant human myeloperoxidase to inhibit the synthesis of hypochlorous acid. Eur J Pharmacol (2007) 0.81
Structure-based design, synthesis, and pharmacological evaluation of 3-(aminoalkyl)-5-fluoroindoles as myeloperoxidase inhibitors. J Med Chem (2010) 0.81
Fibrinolysis and cardiovascular risk factors: association with fibrinogen, lipids, and monocyte count. Eur J Intern Med (2006) 0.80
[Patient with left ventricular aneurysm and thrombus after myocardial infarction - long-term observation]. Kardiol Pol (2011) 0.80
VAP II analysis of lipoprotein subclasses in mixed hyperlipidemic patients on treatment with ezetimibe/simvastatin and fenofibrate. J Lipid Res (2008) 0.80
Postinfarction left ventricular pseudoaneurysm with left-to-right shunt: case report and review of the literature. Int J Cardiol (2008) 0.80
Facilitated percutaneous coronary intervention in patients with acute myocardial infarction transferred from remote hospitals. Am J Cardiol (2003) 0.79
Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors. Eur J Pharmacol (2006) 0.78
Secondary prevention in patients after hospitalisation due to coronary artery disease: what has changed since 2006? Kardiol Pol (2014) 0.78
Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease. Diab Vasc Dis Res (2012) 0.78
[Catheter-based renal sympathetic denervation for the treatment of resistant arterial hypertension in Poland - experts consensus statement]. Kardiol Pol (2011) 0.78
Efficacy and safety of adding fenofibrate 160 mg in high-risk patients with mixed hyperlipidemia not controlled by pravastatin 40 mg monotherapy. Am J Cardiol (2010) 0.77
Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction. Eur J Intern Med (2009) 0.77
Presence of LDL modified by myeloperoxidase in the penis in patients with vascular erectile dysfunction: a preliminary study. Eur Urol (2006) 0.77
Conception of myeloperoxidase inhibitors derived from flufenamic acid by computational docking and structure modification. Bioorg Med Chem (2007) 0.77
Optimization of apolipoprotein-B-100 sequence coverage by liquid chromatography-tandem mass spectrometry for the future study of its posttranslational modifications. Anal Biochem (2010) 0.77
Safety of a fixed-dose combination of fenofibrate/pravastatin 160 mg/40 mg in patients with mixed hyperlipidaemia: a pooled analysis from a database of clinical trials. Clin Drug Investig (2012) 0.76
Dual antiplatelet therapy and antithrombotic treatment in patients with acute coronary syndrome--does everyday medical practice reflects current recommendations? A pilot study. Kardiol Pol (2009) 0.76
Development and validation of a screening procedure for the assessment of inhibition using a recombinant enzyme. Talanta (2007) 0.76
Acute pulmonary embolism registry in the Małopolska region - clinical course. Kardiol Pol (2009) 0.76
Gender does not influence event-free survival in patients with ischaemic heart disease undergoing non-emergency coronary angiography. A single centre analysis. Kardiol Pol (2007) 0.76
Impact of early abciximab administration on myocardial reperfusion in patients with ST-segment elevation myocardial infarction pretreated with 600 mg of clopidogrel before percutaneous coronary intervention. J Thromb Thrombolysis (2010) 0.76
Comment on "a new electrocardiogram finding for massive pulmonary embolism: ST elevation in lead aVR with ST depression in leads I and V(4) to V(6)". Am J Emerg Med (2013) 0.75
[Comment to article Acute coronary syndrome - a frequent clinical manifestation of bare metal in-stent restenosis]. Kardiol Pol (2010) 0.75
Pulse pressure and restenosis after percutaneous coronary angioplasty. Am J Cardiol (2002) 0.75
[Catecholaminergic ventricular tachycardia initially diagnosed as right ventricular outflow tract arrhythmia. Differential diagnosis of CPVT, LQTS and RVOT arrhythmia]. Kardiol Pol (2011) 0.75
[Neurogenic stunning of left ventricle following epileptic seizures in a patient with aortic regurgitation and Niemann-Pick disease]. Kardiol Pol (2011) 0.75
[Polymorphic ventricular tachycardia in acute myocardial infarction without ST elevation in a patient with thrombocytopenia]. Kardiol Pol (2006) 0.75
[Masquerading bundle branch block]. Kardiol Pol (2014) 0.75
Impact of advanced age on the safety and effectiveness of paclitaxel-eluting stent implantation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: The HORIZONS-AMI trial. Catheter Cardiovasc Interv (2013) 0.75
Comparison of short-term renal effects and efficacy of rosuvastatin 40 mg and simvastatin 80 mg, followed by assessment of long-term renal effects of rosuvastatin 40 mg, in patients with dyslipidemia. J Clin Lipidol (2007) 0.75
[Cardiac involvement in Fabry's disease - typical disease course and diagnostic problems]. Kardiol Pol (2011) 0.75
[Myopericarditis complicated with cardiogenic shock mimicking acute coronary syndrome with ST elevation in a patient with hyperthyroidism and diabetes mellitus]. Kardiol Pol (2008) 0.75
[Atypical causes of myocardial infarction--Kounis syndrome]. Przegl Lek (2011) 0.75
Dynamic ECG changes in a patient with subarachnoid haemorrhage. Kardiol Pol (2014) 0.75
[Is homocysteine a new factor in the pathogenesis of restenosis after percutaneous coronary angioplasty?]. Przegl Lek (2003) 0.75
[Malignant form of familial hypertrophic cardiomyopathy complicated with ventricular fibrillation in siblings. Electrocardiogram in hypertrophic cardiomyopathy - a review]. Kardiol Pol (2009) 0.75
[Assessment of myocardial reperfusion in patients with acute myocardial infarction treated with combination of fibrinolysis and IIb/IIIa platelet inhibitor]. Przegl Lek (2002) 0.75
Massive pulmonary embolism due to giant right ventricle thrombus. Kardiol Pol (2013) 0.75
The risk of diabetes development in long-term observation of patients with acute hyperglycaemia during myocardial infarction. Kardiol Pol (2015) 0.75
U wave variability in the surface ECG. Ann Noninvasive Electrocardiol (2014) 0.75
Probucol does not inhibit myeloperoxidase-dependent low-density lipoprotein oxidation as a potent protective effect in atherosclerosis. J Cardiovasc Pharmacol (2007) 0.75
[Acute coronary syndrome with minimal electrocardiographic changes as a manifestation of large, first diagonal branch occlusion]. Kardiol Pol (2008) 0.75
[Arrhythmogenic right ventricular cardiomyopathy with left ventricular involvement mimicking acute coronary syndrome - two case reports]. Kardiol Pol (2011) 0.75
Effects of raloxifene treatment on the phenotype of blood monocytes. Can J Physiol Pharmacol (2010) 0.75
[The influence of percutaneous coronary recanalization of total coronary occlusions on the heart rate variability ]. Przegl Lek (2002) 0.75
Macroscopic T-wave alternans during non-sustained ventricular tachycardia. Europace (2008) 0.75
Electrocardiographic landmarks of hypothermia. Kardiol Pol (2013) 0.75
[Transient left ventricular apical ballooning syndrome--a case report]. Kardiol Pol (2007) 0.75
[Primary percutaneous coronary interventions in acute myocardial infraction with ST-segment elevation. Experience in a heart catheterization unit without surgical backup]. Przegl Lek (2004) 0.75